1. Home
  2. PTVE vs NVAX Comparison

PTVE vs NVAX Comparison

Compare PTVE & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTVE
  • NVAX
  • Stock Information
  • Founded
  • PTVE 1880
  • NVAX 1987
  • Country
  • PTVE United States
  • NVAX United States
  • Employees
  • PTVE N/A
  • NVAX N/A
  • Industry
  • PTVE Containers/Packaging
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PTVE Consumer Discretionary
  • NVAX Health Care
  • Exchange
  • PTVE Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • PTVE 2.1B
  • NVAX 2.0B
  • IPO Year
  • PTVE 2020
  • NVAX 1995
  • Fundamental
  • Price
  • PTVE $12.36
  • NVAX $7.32
  • Analyst Decision
  • PTVE Strong Buy
  • NVAX Buy
  • Analyst Count
  • PTVE 7
  • NVAX 6
  • Target Price
  • PTVE $14.57
  • NVAX $17.83
  • AVG Volume (30 Days)
  • PTVE 226.6K
  • NVAX 5.7M
  • Earning Date
  • PTVE 11-12-2024
  • NVAX 11-12-2024
  • Dividend Yield
  • PTVE 3.25%
  • NVAX N/A
  • EPS Growth
  • PTVE N/A
  • NVAX N/A
  • EPS
  • PTVE N/A
  • NVAX N/A
  • Revenue
  • PTVE $5,197,000,000.00
  • NVAX $885,193,000.00
  • Revenue This Year
  • PTVE N/A
  • NVAX N/A
  • Revenue Next Year
  • PTVE $0.85
  • NVAX N/A
  • P/E Ratio
  • PTVE N/A
  • NVAX N/A
  • Revenue Growth
  • PTVE N/A
  • NVAX N/A
  • 52 Week Low
  • PTVE $8.83
  • NVAX $3.53
  • 52 Week High
  • PTVE $15.84
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • PTVE 60.60
  • NVAX 25.43
  • Support Level
  • PTVE $11.11
  • NVAX $8.84
  • Resistance Level
  • PTVE $12.41
  • NVAX $10.39
  • Average True Range (ATR)
  • PTVE 0.36
  • NVAX 0.66
  • MACD
  • PTVE 0.08
  • NVAX -0.14
  • Stochastic Oscillator
  • PTVE 96.38
  • NVAX 13.35

About PTVE Pactiv Evergreen Inc. Common stock

Pactiv Evergreen Inc is engaged in the business of manufacturing and distributing fresh foodservice and food merchandising products and fresh beverage cartons. It operates in two segments: Foodservice, Food and Beverage Merchandising. These segments manufacture products such as food containers, drinkware, tableware, service ware, ready-to-eat food containers, clear rigid-display containers, trays for meat and poultry, molded fiber egg cartons, printed cartons, spouts & filling machines, and other products. It generates the majority of its revenue from Food and Beverage Merchandising. The company's geographical segments are the United States, the Rest of North America, and Others, of which the vast majority of its revenue comes from the United States.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: